Literature DB >> 33827386

Serum Starvation Sensitizes Anticancer Effect of Anemarrhena asphodeloides via p38/JNK-Induced Cell Cycle Arrest and Apoptosis in Colorectal Cancer Cells.

Kon-Young Ji1, Ki Mo Kim1,2, Yun Hee Kim1, Ki-Shuk Shim1, Joo Young Lee1, Taesoo Kim1, Sungwook Chae1,2.   

Abstract

The molecular mechanism underlying the anticancer effects of Anemarrhena asphodeloides (A. asphodeloides) on colon cancer is unknown. This is the first study evaluating the anticancer effect of A. asphodeloides extract (AA-Ex) in serum-starved colorectal cancer cells. Changes in cell proliferation and morphology in serum-starved MC38 and HCT116 colorectal cancer cells were investigated using MTS assay. Cell cycle and apoptosis were investigated using flow cytometry, and cell cycle regulator expression was determined using qRT-PCR. Apoptosis regulator protein levels and mitogen-activated protein kinase (MAPK) phosphorylation were assessed using western blotting. AA-Ex sensitively suppressed proliferation of serum-starved colorectal cancer cells, with MC38 and HCT116 cells showing greater changes in proliferation after treatment with AA-Ex under serum starvation than HaCaT and RAW 264.7 cells. AA-Ex inhibited cell cycle progression in serum-starved MC38 and HCT116 cells and increased the expression of cell cycle inhibitors (p53, p21, and p27). Furthermore, AA-Ex induced apoptosis in serum-starved MC38 and HCT116 cells. Consistently, AA-Ex suppressed the expression of the anti-apoptotic molecule Bcl-2 and upregulated pro-apoptotic molecules (cytochrome c, cleaved caspase-9, cleaved caspase-3, and cleaved-PARP) in serum-starved cells. AA-Ex treatment under serum starvation decreased AKT and ERK1/2 phosphorylation in the cell survival signaling pathway but increased p38 and JNK phosphorylation. Furthermore, AA-Ex treatment with serum starvation increased the levels of the transcription factors of the p38 and JNK pathway. Serum starvation sensitizes colorectal cancer cells to the anticancer effect of A. asphodeloidesvia p38/JNK-induced cell cycle arrest and apoptosis. Hence, AA-Ex possesses therapeutic potential for colon cancer treatment.

Entities:  

Keywords:  Anemarrhena asphodeloides; Anticancer; Apoptosis; Cell Cycle Arrest; Colon Cancer; p38/JNK Signaling Pathway

Year:  2021        PMID: 33827386     DOI: 10.1142/S0192415X21500488

Source DB:  PubMed          Journal:  Am J Chin Med        ISSN: 0192-415X            Impact factor:   4.667


  5 in total

1.  A Micro-Immunotherapy Sequential Medicine MIM-seq Displays Immunomodulatory Effects on Human Macrophages and Anti-Tumor Properties towards In Vitro 2D and 3D Models of Colon Carcinoma and in an In Vivo Subcutaneous Xenograft Colon Carcinoma Model.

Authors:  Camille Jacques; Irene Marchesi; Francesco Paolo Fiorentino; Mathias Chatelais; Nicoletta Libera Lilli; Kurt Appel; Beatrice Lejeune; Ilaria Floris
Journal:  Int J Mol Sci       Date:  2022-05-27       Impact factor: 6.208

2.  Chemical and Biological Evidence of the Efficacy of Shengxian Decoction for Treating Human Lung Adenocarcinoma.

Authors:  Kejuan Li; Fengming You; Qin Zhang; Ruijiao Yuan; Qianghua Yuan; Xi Fu; Yifeng Ren; Qian Wang; Xiaohong Li; Zhenya Zhang; Mototada Shichiri; Yue Yu
Journal:  Front Oncol       Date:  2022-03-18       Impact factor: 6.244

3.  Magnesium-L-threonate exhibited a neuroprotective effect against oxidative stress damage in HT22 cells and Alzheimer's disease mouse model.

Authors:  Ying Xiong; Yu-Ting Ruan; Jing Zhao; Yu-Wen Yang; Li-Ping Chen; Ying-Ren Mai; Qun Yu; Zhi-Yu Cao; Fei-Fei Liu; Wang Liao; Jun Liu
Journal:  World J Psychiatry       Date:  2022-03-19

4.  Network pharmacology-based investigation and experimental validation of the mechanism of scutellarin in the treatment of acute myeloid leukemia.

Authors:  Zhe Huang; Yan Yang; Xianming Fan; Wenzhe Ma
Journal:  Front Pharmacol       Date:  2022-09-07       Impact factor: 5.988

5.  The Antitumor Effect of Timosaponin A3 through c-Myc Inhibition in Colorectal Cancer Cells and Combined Treatment Effect with 5-FU or Doxorubicin.

Authors:  Hyun Min Ko; Wona Jee; Do-Il Park; Kwan-Il Kim; Ji Hoon Jung; Hyeung-Jin Jang
Journal:  Int J Mol Sci       Date:  2022-10-07       Impact factor: 6.208

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.